The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMATE.L Regulatory News (MATE)

  • There is currently no data for MATE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Research from QuotedData

23 Aug 2022 17:46

RNS Number : 9827W
JPMorgan Multi-Asset Grwth & Income
23 August 2022
 

JPMorgan Multi-Asset Growth & Income - Research from QuotedData

22 August 2022

 

Navigating a changed landscape

 

Measures being taken to tackle inflation are weighing on markets. Reflecting this, JPMorgan Multi-Asset Growth & Income (MATE) has also been affected, with falls in its net asset value (NAV) and share price. However, living up to its objective (see below), these falls have not been as severe as those of global equity markets.

 

In the current environment, MATE's policy of growing its dividend at least in line with inflation should be attractive to investors. The managers have repositioned the portfolio to reflect the changed circumstances. They are looking for signs that the worst is priced in and markets are braced to recover, and will look to take advantage of this when the time is right.

 

Full research:

 

https://quoteddata.com/research/jpmorgan-multi-asset-growth-income-navigating-a-changed-landscape-qd/

 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on JPMorgan Multi-Asset Growth and Income Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors.

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFSRTSIVFIF
Date   Source Headline
26th Mar 20241:05 pmRNSResult 2nd General Meeting & Scheme Entitlements
26th Mar 202410:44 amRNSNet Asset Value(s)
25th Mar 202412:37 pmRNSGearing Announcement
25th Mar 202411:02 amRNSNet Asset Value(s)
25th Mar 20247:30 amRNSSuspension - JPM Multi-Asset Growth & Income PLC
22nd Mar 202411:10 amRNSNet Asset Value(s)
21st Mar 202410:42 amRNSNet Asset Value(s)
20th Mar 202410:35 amRNSNet Asset Value(s)
19th Mar 202410:27 amRNSNet Asset Value(s)
18th Mar 20242:59 pmRNSResult of First General Meeting
18th Mar 202411:46 amRNSGearing Announcement
18th Mar 202411:08 amRNSNet Asset Value(s)
15th Mar 202411:09 amRNSNet Asset Value(s)
14th Mar 202410:53 amRNSNet Asset Value(s)
13th Mar 202410:22 amRNSNet Asset Value(s)
12th Mar 202411:28 amRNSTen Largest Investments
12th Mar 202411:11 amRNSNet Asset Value(s)
11th Mar 202411:47 amRNSGearing Announcement
11th Mar 202410:27 amRNSNet Asset Value(s)
8th Mar 202410:51 amRNSNet Asset Value(s)
7th Mar 202410:48 amRNSNet Asset Value(s)
6th Mar 202410:49 amRNSNet Asset Value(s)
5th Mar 202410:55 amRNSNet Asset Value(s)
4th Mar 202411:53 amRNSGearing Announcement
4th Mar 202411:08 amRNSNet Asset Value(s)
1st Mar 202411:36 amRNSNet Asset Value(s)
29th Feb 202412:16 pmRNSNet Asset Value(s)
28th Feb 202410:58 amRNSNet Asset Value(s)
27th Feb 202411:06 amRNSNet Asset Value(s)
26th Feb 202412:23 pmRNSGearing Announcement
26th Feb 202411:12 amRNSNet Asset Value(s)
23rd Feb 202411:05 amRNSNet Asset Value(s)
23rd Feb 202410:00 amRNSPublication of Circular
22nd Feb 202410:36 amRNSNet Asset Value(s)
21st Feb 202410:53 amRNSNet Asset Value(s)
20th Feb 202410:27 amRNSNet Asset Value(s)
19th Feb 202411:47 amRNSGearing Announcement
19th Feb 202411:15 amRNSNet Asset Value(s)
16th Feb 202410:51 amRNSNet Asset Value(s)
15th Feb 20244:00 pmRNSDividend Declaration
15th Feb 20243:38 pmRNSNet Asset Value(s)
14th Feb 202411:26 amRNSNet Asset Value(s)
13th Feb 202411:22 amRNSNet Asset Value(s)
9th Feb 202410:27 amRNSNet Asset Value(s)
8th Feb 202411:07 amRNSNet Asset Value(s)
7th Feb 202411:15 amRNSNet Asset Value(s)
6th Feb 202410:43 amRNSNet Asset Value(s)
5th Feb 202411:45 amRNSGearing Announcement
5th Feb 202410:36 amRNSNet Asset Value(s)
2nd Feb 202411:53 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.